Castle Rock Wealth Management LLC lifted its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 949.0% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 6,955 shares of the biotechnology company’s stock after acquiring an additional 6,292 shares during the quarter. Castle Rock Wealth Management LLC’s holdings in Axon Enterprise were worth $2,939,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Wedmont Private Capital boosted its holdings in Axon Enterprise by 5,927.3% during the third quarter. Wedmont Private Capital now owns 43,517 shares of the biotechnology company’s stock worth $18,387,000 after purchasing an additional 42,795 shares during the last quarter. WoodTrust Financial Corp lifted its position in shares of Axon Enterprise by 252.2% during the 3rd quarter. WoodTrust Financial Corp now owns 11,676 shares of the biotechnology company’s stock worth $4,933,000 after buying an additional 8,361 shares in the last quarter. Mn Services Vermogensbeheer B.V. boosted its stake in shares of Axon Enterprise by 5,571.4% in the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 1,262,110 shares of the biotechnology company’s stock worth $533,267,000 after buying an additional 1,239,856 shares during the last quarter. First Heartland Consultants Inc. boosted its stake in shares of Axon Enterprise by 2,538.0% in the 3rd quarter. First Heartland Consultants Inc. now owns 24,586 shares of the biotechnology company’s stock worth $10,388,000 after buying an additional 23,654 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Axon Enterprise by 6,472.9% in the third quarter. GAMMA Investing LLC now owns 110,359 shares of the biotechnology company’s stock valued at $46,629,000 after acquiring an additional 108,680 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Insider Buying and Selling at Axon Enterprise
In related news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the transaction, the insider directly owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president owned 296,974 shares of the company’s stock, valued at $170,590,774.82. This represents a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 47,397 shares of company stock worth $26,722,984. 4.20% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Axon Enterprise Stock Performance
Shares of AXON stock traded up $5.58 on Friday, hitting $422.89. 743,866 shares of the stock were exchanged, compared to its average volume of 1,054,714. The firm’s 50 day moving average is $520.54 and its two-hundred day moving average is $476.63. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $764.02. The firm has a market capitalization of $34.35 billion, a PE ratio of 175.47, a P/E/G ratio of 7.64 and a beta of 1.44. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same period in the previous year, the business posted $2.12 EPS. Sell-side analysts expect that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.
The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.
Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
